首页 | 本学科首页   官方微博 | 高级检索  
     


Clinical utility of plasma Epstein‐Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma
Authors:Edwin P. Hui MD  Brigette B. Y. Ma MD  K. C. Allen Chan PhD  Charles M. L. Chan PhD  Cesar S. C. Wong PhD  Ka Fai To MD  Anthony W. H. Chan MD  Stewart Y. Tung MD  Wai‐Tong Ng MD  Ashley C. Cheng MD  Victor H. F. Lee MD  Stephen L. Chan MD  Herbert H. F. Loong MD  Michael K. M. Kam MD  Sing‐Fai Leung MD  Rosalie Ho BSc  Frankie Mo PhD  Roger K. C. Ngan MD  Anthony T. C. Chan MD  FRCP
Affiliation:1. Partner State Key Laboratory of Oncology in South China, Department of Clinical Oncology, Sir Y.K. Pao Center for Cancer, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Special Administrative Region (SAR), China;2. Department of Chemical Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China;3. Department of Health Technology and Informatics, Faculty of Health and Social Sciences, Hong Kong Polytechnic University, Hong Kong SAR, China;4. Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China;5. Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong SAR, China;6. Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China;7. Department of Oncology, Princess Margaret Hospital, Hong Kong SAR, China;8. Department of Clinical Oncology, Queen Mary Hospital, Hong Kong SAR, China;9. Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China
Abstract:
Keywords:biomarker  Epstein‐Barr virus DNA  ERCC1  nasopharyngeal cancer  single nucleotide polymorphism
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号